drugset / Trial / NCT00803686
A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women
RandomizedCrossoverTriple-blindTreatment
Summary
This study is being conducted to assess the plasma CTx-1 concentrations when dosing is at night and to compare these results with those obtained with a placebo control and with commercially available nasal calcitonin.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CALCITONIN SALMON | Protein / enzyme biologic | 200 ug | Oral |
Indications
No indication recorded.